NDBI secures third patent for nuclear diamond battery platform
Nuclear Diamond Batteries, Inc. (OTC: NDBI), a development-stage US company building betavoltaic power systems through its subsidiary AtomiQ, Inc., has received a third Notice of Allowance from the US Patent and Trademark Office, this time covering proprietary methods for synthesising carbon nano-onions from nanodiamond starting materials. The move completes what the company describes as a vertically integrated IP stack, spanning energy conversion architecture, electrode structure, and now the foundational nanomaterials that underpin the entire platform.
The newly allowed application (No. 18/015,242) covers 18 claims relating to the synthesis of carbon nano-onions, concentric, layered carbon nanostructures, produced by annealing nanodiamond material under controlled conditions of atmosphere, temperature, and pressure. The USPTO examiner confirmed the claimed process conditions are distinct from prior published methods, establishing novelty. This third allowance follows patents covering AtomiQ's core nuclear voltaic power-source architecture and a high-porosity metal-organic framework (MOF) electrode coated with these same carbon nano-onion structures, which was allowed in May 2026.
A vertically integrated IP position
The significance for strategic observers is less about the individual patent and more about the architecture of the portfolio. By securing rights across raw-material synthesis, electrode design, and energy conversion in a single cohesive stack, NDBI is positioning AtomiQ as a controlled-supply node for a technology that cannot easily be reverse-engineered at the component level. Most early-stage deep-tech competitors hold process patents or device patents; few hold both simultaneously alongside the upstream materials methods. Whether that integrated position translates into commercial leverage depends heavily on regulatory clearance: the handling and encapsulation of radioisotopes requires licensing from the US Nuclear Regulatory Commission, and the company has not yet commenced production.
The company explicitly targets space applications as its primary commercial horizon. Nuclear diamond batteries, which convert beta radiation from radioisotope decay directly into electricity, are suited to environments where conventional power sources fail: deep-space probes, small-satellite subsystems, and sensor networks that must operate for years or decades without servicing. Conventional radioisotope thermoelectric generators (RTGs) have powered NASA missions for decades but are large and thermally intensive. The company says compact betavoltaic systems can address lower-power platforms that RTGs cannot serve economically.
Cross-sector read-across: energy, space, and defence procurement
The broader convergence story here spans three sectors. In the space economy, a new generation of small-satellite constellations and deep-space missions is creating acute demand for power sources that outlast lithium-ion chemistries and do not require solar exposure. The commercial space sector's rapid capital expansion, illustrated by large IPO activity in mid-2026, is drawing investor attention toward enabling technologies rather than launch vehicles alone. Power systems that can underwrite decade-long satellite lifespans are a quiet bottleneck in that buildout.
In defence and dual-use markets, betavoltaic power sits at the intersection of energy security and sovereign manufacturing. The US Department of Defense has signalled sustained interest in domestic radioisotope supply chains, and a domestically patented, domestically manufactured nuclear battery platform carries geopolitical appeal that a conventional chemistry battery cannot replicate. That framing also connects to the broader industrial-policy push under successive US administrations to reshore critical materials and components. NDBI's approach, which converts radioactive byproduct waste streams into encapsulated battery cells, adds a waste-reduction narrative that could ease regulatory and ESG-related capital barriers over time.
For capital allocators watching the intersection of deep-tech and defence-adjacent energy infrastructure, the company's OTC listing and development-stage status signal early-innings risk. The IP portfolio is a meaningful asset, but commercial viability depends on regulatory milestones that have not yet been reached, and the company itself acknowledges that a Notice of Allowance is not a granted patent until issue fees are paid. The next material data points to watch are NRC licensing progress and any announced co-development partnerships, which the company's pending applications hint at.